ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ELOG vs TMO // EV/EBITDA & P/E VALUATION

Eastern International Ltd. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ELOG 1 — TMO 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELOG VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ELOG TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 9.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 9.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield — 2.40% — TIE /fcf-yield <GO>
Operating Margin -2.30% 17.40% -19.70 TMO /operating-margins <GO>
Net Profit Margin -2.50% 15.10% -17.60 TMO /net-margins <GO>
Revenue Growth (YoY) 14.00% 3.90% +10.10 ELOG /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 8/9 -7.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.5 62.9 -16.40 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $10.3M $262.22B -$262.21B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ELOG REV TMO REV ELOG GROSS % TMO GROSS % ELOG FCF TMO FCF
FY 2025 $45.6M $44.56B 9.3% — -$3.5M $6.29B
FY 2024 $40.0M $42.88B 15.0% — -$2.6M $7.27B
FY 2023 $40.4M $42.86B — — -$629.8K $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELOG // BETA —
TMO // BETA 0.94